Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1028220170290040228
Hip & Pelvis
2017 Volume.29 No. 4 p.228 ~ p.233
Primary Total Hip Arthroplasty Using Summit¢ç Stems in Korean: Minimum Four-year Follow-up
Yoon Jae-Sik

Kang Joon-Sun
Moon Kyoung-Ho
Abstract
Purpose: The aim of this study was to assess the mid-term results of primary cementless total hip arthroplasty (THA) using Summit¢ç stems.

Materials and Methods: One hundred twenty-eight arthroplasties in 121 patients who were performed THA from December 2004 to March 2013, were reviewed retrospectively a minimum of 4 years follow-up (mean age, 60.3 years; mean postoperative follow up period, 86.3 months). For a clinical evaluation, the Harris hip score (HHS) was used to assess outcome. Radiographic evaluation was done through spot welds, subsidence, stress shielding, canal filling.

Results: The mean HHS was 69.8 points preoperatively, and it improved significantly to 96.3 points at the final follow-up. Postoperatively, 10 patients experienced thigh pain and 7 patients showed a moderate limping gait. There was not only early stem subsidence but there was no more subsidence at last follow up. One hundred eighteen hips showed radiographic signs of stem bone ingrowth, and 10 hips showed fibrous ingrowth at the last follow-up. Stress shielding occurred in 85 hips and third degree stress shielding was observed in 6 hips. Complication arose in 10 hips due to dislocation. Although revisions due to recurrent dislocations led to acetabular component revision in one hip, no revisions arose due to isolated aseptic loosening of the femoral component.

Conclusion: The clinical and radiological mid-term results of primary THA using Summit¢ç stems revealed solid initial fixation and bone ingrowth stable fixation. Considering the satisfactory clinical results, Summit¢ç stems may be a good treatment option in Korean patients who were required hip arthroplasty
KEYWORD
Femur, Summit¢ç stem, Hip replacement arthroplast
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed